It was reported that patient was admitted on (b)(6) 2020 from community emergency department (ed) for incessant ventricular tachycardia (vt), for which patient's implantable cardioverter-defibrillator (icd) failed to shock him.After admit to cardiovascular intensive care unit (cvicu), direct current cardioversion (dcc) was performed and patient was returned to normal sinus rhythm (nsr).Patient underwent a right heart catheterization (rhc) on (b)(6) 2020 and discovered mod right ventricular (rv) dysfunction (unchanged from preimplant) and normal cardiac output (co) and cardiac index (ci).Due to return to vt, a bilateral sympathectomy was performed on (b)(6) 2020, but patient continued with vt post-procedure and required conversion.His amiodarone was increased.On (b)(6) 2020, patient experienced a hypoxic respiratory arrest, believed to be rv related by his care team, and was intubated (b)(6) 2020 - (b)(6) 2020.Since that event, he experienced delirium and failed swallow study.The are continuing with supportive measures.
|
Manufacturer's investigation conclusion: a direct correlation between the device and the reported ventricular tachycardia, right ventricle dysfunction, hypoxic respiratory arrest, and neurological issues following intubation could not be determined through this evaluation.However, it was reported that the patient's right ventricle dysfunction was a preexisting condition and was unchanged from preimplant.It was reported that the patient was directly admitted on (b)(6) 2020 (approximately 4 months post-implant) from the community emergency department for incessant ventricular tachycardia (vt), for which the patient's implantable cardioverter defibrillator (icd) failed to shock him.After admission to the cardiovascular intensive care unit (cvicu), direct current conversion (dcc) was performed and the patient was returned to normal sinus rhythm (nsr).The patient underwent a right heart catheterization (rhc) on (b)(6) 2020, which revealed moderate right ventricle (rv) dysfunction with normal cardiac output (co) and cardiac index (ci).It was reported that the patient¿s rv dysfunction was unchanged from preimplant.Information provided indicated that a bilateral sympathectomy was performed on (b)(6)2020 due to recurring vt, but the patient continued to experience vt post-procedure and required conversion.His amiodarone dosage was also increased.The patient then experienced a hypoxic respiratory arrest on (b)(6) 2020, which was believed to be rv related by his care team.The patient was intubated from (b)(6) 2020.Since that event, he experienced delirium and failed a swallow study.The center continued with supportive measures.No alarms or functional issues with the lvas were reported in association with the event.The patient remains ongoing on (b)(6) and no additional events have been reported at this time.The heartmate 3 lvas ifu lists cardiac arrhythmia, right heart failure, respiratory failure, and other neurological event (not stroke-related) as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.No further information was provided.The manufacturer is closing the file on this event.
|